Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.6500
-0.0130
(-1.96%)
At close: March 4 at 4:00:01 PM EST
0.6909
+0.04
+(6.29%)
After hours: March 4 at 6:44:44 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-25,244
-28,448
-23,355
-22,433
-22,068
Investing Cash Flow
-236
20,222
-20,403
-286
-29
Financing Cash Flow
5,039
31,994
12,205
33,015
39,773
End Cash Position
19,540
34,912
11,666
41,262
31,220
Income Tax Paid Supplemental Data
--
120
46
35
12
Capital Expenditure
-236
-8
-55
-286
-29
Issuance of Capital Stock
4,951
31,620
12,574
32,912
38,296
Repayment of Debt
-352
-407
-381
-366
-461
Free Cash Flow
-25,480
-28,456
-23,410
-22,719
-22,097
12/31/2020 - 10/5/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CRDF Cardiff Oncology, Inc.
3.7350
-2.10%
IRD Opus Genetics, Inc.
1.0000
+2.90%
NNVC NanoViricides, Inc.
1.2100
+1.68%
AGEN Agenus Inc.
2.5800
+1.57%
QNRX Quoin Pharmaceuticals, Ltd.
0.2950
-2.64%
MCRB Seres Therapeutics, Inc.
0.6701
-10.50%
MRSN Mersana Therapeutics, Inc.
0.5083
+5.90%
SKYE Skye Bioscience, Inc.
2.5600
+1.99%
CADL Candel Therapeutics, Inc.
7.88
-0.38%
ENTO Entero Therapeutics, Inc.
0.5089
-16.57%